The role of lithium in the treatment of psychiatric disorders has engendered a longstanding and intense debate. Despite well-established efficacy as an acute and prophylactic treatment of bipolar disorder, many residents in training have never been taught how to use lithium. Moreover, although lithium is cited by guidelines in Canada and around the world as the gold standard for acute and prophylactic treatment, many psychiatrists appear to doubt the effectiveness.
In his new book, Professor Schioldann brings a historical context to the controversy. In the minds of most psychiatrists, the names of John Cade and Mogens Schou are associated with the discovery of lithium treatment as an effective antimanic and prophylactic agent. Yet, after a careful historical analysis, Professor Schioldann credits priority of scientific discovery to Frederik and Carl Lange, 2 Danish physicians who were active over a century ago. Schioldann's book comes to a surprising conclusion that, in essence, it was the Lange brothers who were the first to use lithium systematically in mood disorders and must be considered founding fathers of lithium therapy. However, as their use of lithium was based on the fallacious hypothesis of uric acid diathesis, it fell into oblivion. As Mogens Schou was a Dane and John Cade Australian, Schioldann, emeritus professor of psychiatry at the University of Adelaide and a Dane living in Australia seemed predestined for this historical exploration.
Schioldann's scholarly, detailed investigation into the way in which lithium was introduced into psychiatric treatment represents a helpful contribution to the study of the history of psychiatry. The book is an erudite and rigorous account of a fascinating era in medical history and an easy one to read. Anyone interested in the history of psychiatry and lithium will profit in particular, but the analysis is also relevant for advancing and remapping the early history of psychopharmacology in general. Earlier maps were incomplete, as Schioldann points out.
Like other disciplines, psychiatry benefits from a good understanding of its historical roots and scientific heroes. Schioldann's book also illustrates that an important discovery is often made by a chain of several people; and who we eventually consider the hero eventually depends on many factors such as who was the most articulate and who was the more in synchrony with the spirit of times. Further, the book also demonstrates, particularly tellingly on the case of lithium therapy, that the history of psychiatry has usually been constructed from a particular angle and that the past protagonists are often chosen to firm up the current views.
The Preface by Gerrman Berrios is a fascinating treatise worthy of reading on its own: it outlines the interesting principles of the epistemology of historiography. As Professor Barrios points out, this book triggers broader historiographical reflections and such considerations are timely. There are many indications that psychiatry has entered an era of conceptual transformation. 1, 2 To deal with such challenges, historical perspectives, such as where we have been and how we got here, are indispensable and helpful.
The book focuses on the question: who was actually the first founder of lithium's effectiveness? But whatever the earlier history, it was not until the experimental work of John Cade and the systematic, determined, long-term research of Mogens Schou, and the intellectual battles he fought, that lithium found its firm place in psychiatry. The discovery and proof of lithium's role in treating psychiatric illnesses has helped to change the face of the discipline and reestablish psychiatric disorders as medical diseases. The Appendix written by Mogens Schou months prior to his passing, "My Journey With Lithium," stands as a comprehensive and articulate summary of the more recent past.
